Romet-Lemonne Jean-Loup 4

Accession 0000822206-05-000018

CIK 0000822206other

View on SEC.gov Company Profile

Filed

Aug 17, 8:00 PM ET

Accepted

Aug 18, 9:13 PM ET

Size

17.6 KB

Accession

0000822206-05-000018

Insider Transaction Report

Form 4

Period: 2005-08-16

IDM PHARMA, INC.IDMI

Romet-Lemonne Jean-Loup

DirectorChairman and CEO

Transactions

PurchaseSwap
Common Stock
2005-08-16+324,867→ 324,867 total
AwardSwap
Employee Stock Option (right to buy)
2005-08-16+68,648→ 68,648 total
Exercise: $6.99From: 2006-03-06Exp: 2012-03-05→ Common Stock (68,648 underlying)
Award
Employee Stock Option (right to buy)
2005-08-16+77,757→ 77,757 total
Exercise: $6.99From: 2006-08-16Exp: 2015-08-16→ Common Stock (77,757 underlying)
Award
Restricted Stock Units
2005-08-16+25,671→ 25,671 total
From: 2006-08-16Exp: 2005-08-16→ Common Stock (25,671 underlying)
AwardSwap
Employee Stock Option (right to buy)
2005-08-16+16,165→ 16,165 total
Exercise: $6.99From: 2007-12-11Exp: 2013-12-10→ Common Stock (16,165 underlying)

Footnotes (10)

[F1]The shares of common stock were acquired in an exchange of shares of IDM S.A. for the shares of IDM Pharma, Inc. At the time of the exchange, each share of IDM S.A. was exchanged for 3.771865 shares of IDM Pharma, Inc. common stock, and adjusted for a 1 for 7 reverse stock split of the common stock of IDM Pharma, Inc.
[F10]The restricted stock units will vest 100% on 08/16/2005, one year from date of grant, and will be delivered to the reporting person.
[F2]N/A
[F3]Grant to reporting person of an incentive stock option to purchase shares of the common stock of IDM Pharma, Inc. pursuant to the terms of the Company's 2000 Stock Plan.
[F4]The option to purchase shares of the common stock of IDM Pharma, Inc. was acquired in an option exchange for a similar option to purchase shares of the common stock of IDM S.A. At the time of the exchange, the option to puchase each share of IDM S.A. common stock was exchanged for the option to purchase 3.771865 shares of IDM Pharma, Inc. common stock, and adjusted for a 1 for 7 reverse stock split of the common stock of IDM Pharma, Inc.
[F5]The option will be vested to the same extent as the IDM S.A. option for which it was exchanged as of the date the substitute option was granted, and will continue to vest in accordance with the vesting schedule applicable to the related IDM S.A. option.
[F6]The IDM S.A. option, for which this option was exchanged, fully vests (100%) and becomes exercisable on 03/06/2006, four years from the original date of grant of the IDM S.A. option, and will expire on 03/05/2012, ten years from the original date of grant of the IDM S.A. option.
[F7]The IDM S.A. option, for which this option was exchanged, fully vests (100%) and becomes exercisable on 12/11/2007, four years from the original grant date of the IDM S.A. option, and will expire on 12/10/2013, ten years from the original grant date of the IDM S.A. option.
[F8]25% of the shares vest and are exercisable on 08/16/2006, one year from date of grant. The remaining shares vest daily over the next three years, and will be fully vested on 08/16/2010.
[F9]Each restricted stock unit represents a contingent right to receive one share of IDM Pharma, Inc. common stock.

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

IDM PHARMA, INC.

CIK 0000822206

→

Entity typeother

Related Parties

filerCIK 0001335836

Filing Metadata

Form type: 4
Filed: Aug 17, 8:00 PM ET
Accepted: Aug 18, 9:13 PM ET
Size: 17.6 KB

View on SEC.gov